Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone in Critical Illness
NCT00409097Phase 3Unknown
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rosiglitazone in critical illness, sponsored by Amsterdam University Medical Center. Status: unknown.
02
Drugs
rosiglitazone
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT00409097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409097.